Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 202960
Company: AMNEAL PHARMS
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
ATOVAQUONE ATOVAQUONE 750MG/5ML SUSPENSION;ORAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
03/18/2014 ORIG-1 Approval Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/202960Orig1s000ltr.pdf

ATOVAQUONE

SUSPENSION;ORAL; 750MG/5ML
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
ATOVAQUONE ATOVAQUONE 750MG/5ML SUSPENSION;ORAL Prescription No AB 202960 AMNEAL PHARMS
ATOVAQUONE ATOVAQUONE 750MG/5ML SUSPENSION;ORAL Prescription No AB 209750 APOTEX INC
ATOVAQUONE ATOVAQUONE 750MG/5ML SUSPENSION;ORAL Prescription No AB 207833 PADDOCK LLC
MEPRON ATOVAQUONE 750MG/5ML SUSPENSION;ORAL Prescription Yes AB 020500 GLAXOSMITHKLINE LLC

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English